Responses
Clinical trials and drug discovery
Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus
Compose a Response to This Article
Other responses
No responses have been published for this article.